Patient Tailored Contrast Volume for Preoperative CT Angiography of the Aorta
NCT ID: NCT05716568
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2014-04-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coronary Artery and Coronary Artery Bypass Graft Imaging Using a Specialized Catheter and Computed Tomography
NCT00474565
Development of Ultra-Low Dose CT Based Screening for Aortic Aneurysms
NCT03479164
Study of the Aorta Adaptations to Exercise in Triathletes During Sports Season (CoATri)
NCT03356301
Impact of Aortic Geometry on Vascular Remodeling After Stent Implantation in Coarctation of the Aorta
NCT07131111
Contrast Enhanced Ultrasound vs. Computed Tomographic Angiography in the Detection of Endoleaks Following AAA Repair
NCT01230684
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For this purpose, we researched previous literature as well as data from previously scanned patients with standard dose, to formulate a contrast dose calculation adapted to patient parameters.
An in-house calculator was developed to calculate the optimal contrast dose dependent on patient length, weight and heartrate.
A total of 60 CT-scans will be performed and retrospectively collected. Patients are randomly assigned to one of three groups : 1/ Standard dose of 120ml; 2/ Calculated dose (40-150ml) 3/ Calculated dose -50% (20-120ml). In case of reduced kidney function, patients were randomly divided between group 2 and 3 (reduced contrast dose).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard contrast dose
Standard contrast dose administration
Contrast dose reduction, CT-angiography
Contrast dose reduction for CT-angiography in pre-operative aorta
Calculated contrast dose
Contrast dose by calculation
Contrast dose reduction, CT-angiography
Contrast dose reduction for CT-angiography in pre-operative aorta
Calculated contrast dose -50%
Contrast dose by calculation, with extra dilution by 50%.
Contrast dose reduction, CT-angiography
Contrast dose reduction for CT-angiography in pre-operative aorta
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Contrast dose reduction, CT-angiography
Contrast dose reduction for CT-angiography in pre-operative aorta
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For aneurysm detection or follow-up
* Or for dissection follow-up
* Thoraco-abdominal aorta or abdominal aorta
Exclusion Criteria
* Previously endovascular repair of the aorta
* Only thoracic aorta
* No informed consent
* Contrast injection at 4cc/second not possible
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Geert Maleux, Prof Dr
Role: PRINCIPAL_INVESTIGATOR
Universitaire Ziekenhuizen KU Leuven
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S58042
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.